ReNetx
is a biotechnology company that offers therapeutics for spinal disorders... Read moreReNetx
is a biotechnology company that offers therapeutics for spinal disorders... Read more
News
Jun 14, 2024
Pharamceutical Technology
ReNetx: AXER-204 by ReNetX Bio for Chronic Spinal Cord Injury: Likelihood of Approval
Jan 08, 2020
centralcharts
Press Release: ReNetx : ReNetX Bio Receives Fast Track Designation From U.S. FDA
Aug 14, 2019
GlobeNewswire
Press Release: ReNetx : ReNetX Bio Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of Fusion Protein AXER-204
Jun 21, 2019
Pharmabiz
ReNetx: ReNetX Bio receives US FDA nod to begin phase 1 trial of AXER─204 to treat chronic spinal cord injury
Jun 19, 2019
PR Newswire
Press Release: ReNetx : ReNetX Bio, Inc. Announces U.S. FDA Authorization to Proceed for IND Application to Treat Patients with Chronic Spinal Cord Injury
Apr 10, 2018
GlobeNewswire
Press Release: ReNetx : ReNetX Bio Invited to Present Breakthrough at Leading Spinal Cord Injury Symposium
Mar 29, 2018
sec
ReNetx: Received $1.7M in Equity Funding
Feb 12, 2018
StreetInsider
Press Release: ReNetx : Remedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory Board
Nov 07, 2017
PharmiWeb
ReNetx: ReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to Trial
Nov 07, 2017
EconoTimes
Press Release: ReNetx : ReNetX Bio Receives $7M Commitment from Wings for Life to Bring Spinal Cord Treatment to Trial
ReNetx Competitors
1
2
3
4
5
6
7
8
9
10